STRYKER CORP Operating Lease, Expense
STRYKER CORP (SYK) reported Operating Lease, Expense of $205.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-02-11
- STRYKER CORP operating lease, expense for fiscal 2025 was $205.00M, a 7.89% increase from fiscal 2024.
- STRYKER CORP operating lease, expense for fiscal 2024 was $190.00M, a 10.47% increase from fiscal 2023.
- STRYKER CORP operating lease, expense for fiscal 2023 was $172.00M, a 15.44% increase from fiscal 2022.
- STRYKER CORP operating lease, expense for fiscal 2022 was $149.00M, a 12.03% increase from fiscal 2021.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2025-12-31 | $205.00M 10-K · filed 2026-02-11 |
| 2024-12-31 | $190.00M 10-K · filed 2026-02-11 |
| 2023-12-31 | $172.00M 10-K · filed 2026-02-11 |
| 2022-12-31 | $149.00M 10-K · filed 2025-02-12 |
| 2021-12-31 | $133.00M 10-K · filed 2024-02-14 |
| 2020-12-31 | $130.00M 10-K · filed 2023-02-10 |
| 2019-12-31 | $133.00M 10-K · filed 2022-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |